Clinical Trial Update: Renal Function Among Thalassemia Patients Treated by a Oral Chelator Deferasirox

View source ↗

Summary

A completed clinical trial evaluating renal function in thalassemia patients with iron overload treated with the oral chelator deferasirox.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Iron Overload
• Thalassemia

Drugs mentioned

• Deferasirox (Deferasirox)

Snippet

Sponsor: HaEmek Medical Center, Israel | Conditions: Thalassemia, Iron Overload | Status: COMPLETED